Index/Topics/Ivermectin FDA approval

Ivermectin FDA approval

Ivermectin is FDA-approved for two human parasitic infections: intestinal strongyloidiasis and onchocerciasis.

Fact-Checks

5 results

Jan 17, 2026

What are the FDA‑approved dosing labels for each specific human ivermectin product (by brand and indication)?

Two oral human ivermectin tablet products carry FDA-approved parasitic indications with weight‑based single‑dose regimens: marketed Stromectol/ivermectin tablets (designed to provide ~200 mcg/kg for s...

Jan 18, 2026

What are the standard dosing regimens for oral ivermectin by indication (strongyloidiasis, onchocerciasis, scabies) according to FDA labeling and dosing guides?

Oral ivermectin (Stromectol) is FDA‑approved for two human parasitic infections: intestinal strongyloidiasis and onchocerciasis; the FDA label documents a single 200 micrograms/kg dose for strongyloid...

Jan 18, 2026

What are the recommended weight‑based ivermectin dosing schedules for common parasitic infections?

Ivermectin dosing for human parasitic infections is weight‑based and typically ranges from about 150 to 400 micrograms per kilogram (mcg/kg) depending on the pathogen, the clinical scenario, and publi...

Jan 16, 2026

What are the FDA‑approved numeric dosing regimens (mg/kg and schedule) for ivermectin in its labeled human indications?

The FDA‑approved oral ivermectin (Stromectol) for human parasitic infections is dosed by body weight, most commonly as a single dose in the range of 150 to 200 micrograms per kilogram (mcg/kg) dependi...